Adiponectin Protects Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Suppressing Autophagy

Area of Science:

• Cardiovascular Biology
• Cellular Signaling
• Autophagy Research

Background:

• Adiponectin, a cytokine from adipocytes, shows potential cardioprotective effects, particularly in myocardial ischemia/reperfusion injury.
• Autophagy plays a critical role in cellular responses to stress, including hypoxia/reoxygenation in cardiomyocytes.

Purpose of the Study:

• To investigate the role of adiponectin-mediated autophagy in its cardioprotective effects during myocardial hypoxia/reoxygenation.
• To elucidate the specific signaling pathways involved in adiponectin's modulation of autophagy in cardiomyocytes.

Main Methods:

• Neonatal rat ventricular myocytes were subjected to hypoxia/reoxygenation, with or without adiponectin and rapamycin.
• Cell viability was assessed using the MTT assay.
• Western blotting analyzed key autophagy-related proteins (LC3B, AMPK, mTOR, p62, ULK1, Beclin-1), and autophagosome formation was visualized via monodansylcadaverine staining.

Main Results:

• Hypoxia/reoxygenation reduced cardiomyocyte viability and increased autophagy, which was further exacerbated by reoxygenation.
• Adiponectin treatment mitigated hypoxia/reoxygenation-induced cell damage and autophagy, even with rapamycin, partly by inhibiting vacuolar H+-ATPase.
• Adiponectin suppressed autophagy by modulating the AMPK/mTOR/ULK1/Beclin-1 pathway, indicated by altered phosphorylation and protein levels.

Conclusions:

• Adiponectin confers cardioprotection against ischemia/reperfusion injury by suppressing excessive autophagy in cardiomyocytes.
• The protective mechanism involves the inhibition of the AMPK/mTOR/ULK1/Beclin-1 signaling cascade.
• Adiponectin represents a potential therapeutic target for managing myocardial ischemia/reperfusion injury.